COVID-19 pandemic has severely impacted the public health and social economy worldwide. A safe, effective, and affordable vaccine against SARS-CoV-2 infections/diseases is urgently needed. We have been developing a recombinant vaccine based on a prefusion-stabilized spike trimer of SARS-CoV-2 and formulated with aluminium hydroxide and CpG 7909. The spike protein was expressed in Chinese hamster ovary (CHO) cells, purified, and prepared as a stable formulation with the dual adjuvant. Immunogenicity studies showed that candidate vaccines elicited robust neutralizing antibody responses and substantial CD4 + T cell responses in both mice and non-human primates. And vaccine-induced neutralizing antibodies persisted at high level for at least 6 months. Challenge studies demonstrated that candidate vaccine reduced the viral loads and inflammation in the lungs of SARS-CoV-2 infected golden Syrian hamsters significantly. In addition, the vaccine-induced antibodies showed cross-neutralization activity against B.1.1.7 and B.1.351 variants. These data suggest candidate vaccine is efficacious in preventing SARS-CoV-2 infections and associated pneumonia, thereby justifying ongoing phase I/II clinical studies in China (NCT04982068 and NCT04990544).
【저자키워드】 SARS-CoV-2, Trimeric spike protein, Subunit vaccine, 【초록키워드】 neutralizing antibody, public health, Inflammation, Vaccine, immunogenicity, Pneumonia, Neutralizing antibodies, B.1.351, SARS-COV-2 infection, COVID-19 pandemic, lung, CD4, Spike protein, China, T cell, Viral, Viral load, cells, B.1.1.7, mice, non-human primates, challenge, Lungs, hamster, SARS-CoV-2 infections, T cell response, Neutralizing antibody response, CpG, clinical study, B.1.351 variants, Safe, dual, aluminium hydroxide, Chinese hamster, recombinant vaccine, vaccine-induced antibodies, These data, viral loads, Aluminium, hydroxide, candidate vaccine, neutralizing antibody responses, prefusion, cross-neutralization activity, inflammation in the lungs, spike trimer, effective, robust, significantly, addition, reduced, expressed, demonstrated, elicited, purified, impacted, vaccine-induced antibody, 【제목키워드】 adjuvant, development, recombinant COVID-19 vaccine, spike trimer,